Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00027378 · ClinicalTrials.gov registry record · Phase 2
Pharmacological Intervention Project (Fluoxetine)
A Phase 2 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00027378 is a Phase 2 study that has completed, run by University of Pittsburgh. The registered enrollment target is 50 participants.
The verdict
NCT00027378, a Phase 2 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a large scale study involving fluoxetine (Prozac) versus a placebo in the treatment of adolescents with alcohol use disorder (AUD) and major depression (MDD). All individuals will receive treatment for 12 weeks with a followup phase lasting 9 months.
Interventions
- DRUG fluoxetine (Prozac)
- DRUG Placebo plus Treatment As Usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2001-07 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00027378
The ClinicalTrials.gov registry entry for NCT00027378 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which fluoxetine (Prozac) is the first listed.
NCT00027378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00027378 about?
NCT00027378 is a clinical study titled "Pharmacological Intervention Project (Fluoxetine)". This is a large scale study involving fluoxetine (Prozac) versus a placebo in the treatment of adolescents with alcohol use disorder (AUD) and major depression (MDD). All individuals will receive treatment for 12 weeks with a followup phase lasting 9 months.
What is the current status of trial NCT00027378?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2001-07. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00027378?
The interventions under investigation include: fluoxetine (Prozac) (DRUG), Placebo plus Treatment As Usual (DRUG).
Who is sponsoring clinical trial NCT00027378?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.